References
- Gardner SD, Field AM, Coleman DV, et al. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1971;297:1253–1257.
- Sawinski D, Goral S. BK virus infection: an update on diagnosis and treatment. Nephrol Dial Transplant. 2015;30:209–217.
- Egli A, Infanti L, Dumoulin A. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis. 2009;199:837–846.
- Vigil D, Konstantinov NK, Barry M, et al. BK nephropathy in the native kidneys of patients with organ transplants: clinical spectrum of BK infection. World J Transplant. 2016;6:472–504.
- Hirsch HH, Randhawa P. BK polyomavirus in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):179–188.
- Bressollette-Bodin C, Coste-Burel M, Hourmant M, et al. A prospective longitudinal study of BK virus infection in 104 renal transplant recipients. Am J Transplant. 2005;5:1926–1933.
- Dekeyser M, François Hélène, Beaudreuil Séverine, et al. Polyomavirus-specific cellular immunity: from BK-virus-specific cellular immunity to BK-virus-associated nephropathy. Front Immunol. 2015;6:307.
- Pai D, Mann DM, Malik A, et al. Risk factors for the development of BK virus nephropathy in renal transplant recipients. Transplant Proc. 2015;47:2465–2469.
- Costa C, Cavallo R. Polyomavirus-associated nephropathy. World J Transplant. 2012;2:84–94.
- Pollara CP, Corbellini S, Chiappini S, et al. Quantitative viral load measurement for BKV infection in renal transplant recipients as a predictive tool for BKVAN. New Microbiol. 2011;34:165–171.
- Hirsch HH, Vincenti F, Friman S, et al. Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study. Am J Transplant. 2013;13:136–145.
- Jamboti JS. BK virus nephropathy in renal transplant recipients. Nephrology (Carlton). 2016;21:647–654.
- Pham PT, Schaenman J, Pham PC. BK virus infection following kidney transplantation: an overview of risk factors, screening strategies, and therapeutic interventions. Curr Opin Organ Transplant. 2014;19:401–412.
- Velioglu A, Aksu B, Asicioglu E, et al. Association of BK virus titers with lymphocyte count in renal transplant patients. Transplant Proc. 2015;47:1421–1424.
- Hirsch HH, Yakhontova K, Lu M, et al. BK polyomavirus replication in renal tubular epithelial cells is inhibited by Sirolimus, but activated by Tacrolimus through a pathway involving FKBP-12. Am J Transplant. 2016;16:821–832.
- Borni-Duval C, Caillard S, Olagne J, et al. Risk factors for BK virus infection in the era of therapeutic drug monitoring. Transplantation 2013;95:1498–1505.
- Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med. 2002;347:488–496.
- Awadalla Y, Randhawa P, Ruppert K, et al. HLA mismatching increases the risk of BK virus nephropathy in renal transplant recipients. Am J Transplant. 2004;4:1691–1696.